| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99284 |
Emergency department visit for the evaluation and management, high severity |
41,402 |
36,965 |
$5.88M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
38,520 |
35,258 |
$5.82M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
41,736 |
36,613 |
$5.43M |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
10,926 |
3,565 |
$4.97M |
| 95810 |
Polysomnography; sleep staging with 4 or more additional parameters |
1,770 |
1,603 |
$3.52M |
| 71045 |
Radiologic examination, chest; single view |
16,697 |
14,607 |
$2.20M |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
35,561 |
31,211 |
$1.92M |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
28,293 |
24,419 |
$1.75M |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
3,997 |
3,475 |
$1.30M |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
12,395 |
7,598 |
$928K |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
5,456 |
4,640 |
$736K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
19,936 |
17,104 |
$707K |
| 95811 |
|
327 |
293 |
$574K |
| 71046 |
Radiologic examination, chest; 2 views |
6,421 |
5,668 |
$536K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
3,015 |
1,601 |
$502K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
6,108 |
4,572 |
$482K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
5,078 |
4,541 |
$410K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
90,217 |
75,978 |
$383K |
| 76811 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed |
2,250 |
2,064 |
$370K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
3,877 |
1,303 |
$357K |
| 80320 |
|
3,555 |
3,066 |
$344K |
| 80053 |
Comprehensive metabolic panel |
54,272 |
46,116 |
$336K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
9,497 |
8,435 |
$324K |
| 59025 |
Fetal non-stress test |
1,134 |
869 |
$297K |
| 70450 |
Computed tomography, head or brain; without contrast material |
3,550 |
3,081 |
$282K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
6,389 |
5,587 |
$269K |
| 36415 |
Collection of venous blood by venipuncture |
75,659 |
64,847 |
$254K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
1,289 |
1,238 |
$161K |
| 99218 |
|
246 |
129 |
$129K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
180 |
152 |
$128K |
| 84484 |
|
22,873 |
15,431 |
$128K |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
716 |
244 |
$122K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
13,485 |
11,136 |
$121K |
| U0004 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r |
1,644 |
1,484 |
$116K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
1,826 |
1,552 |
$115K |
| 76819 |
Fetal biophysical profile; without non-stress testing |
936 |
475 |
$110K |
| 87503 |
|
4,182 |
3,808 |
$100K |
| 36591 |
|
1,422 |
782 |
$96K |
| 95806 |
|
283 |
224 |
$95K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
2,456 |
2,268 |
$88K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
820 |
754 |
$67K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
1,164 |
1,011 |
$66K |
| 81025 |
|
11,717 |
10,373 |
$63K |
| 77336 |
|
565 |
161 |
$62K |
| 99221 |
|
110 |
92 |
$61K |
| 76801 |
|
476 |
436 |
$61K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
12,675 |
10,856 |
$59K |
| 62323 |
|
107 |
91 |
$58K |
| 76818 |
|
615 |
246 |
$57K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
954 |
863 |
$57K |
| 80348 |
|
384 |
186 |
$55K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
717 |
567 |
$52K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
849 |
730 |
$51K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
1,953 |
1,755 |
$51K |
| 80050 |
General health panel |
451 |
355 |
$49K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
629 |
572 |
$48K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
1,837 |
1,647 |
$47K |
| 83690 |
|
15,656 |
13,779 |
$47K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
1,239 |
1,045 |
$44K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,912 |
1,532 |
$44K |
| 84443 |
Thyroid stimulating hormone (TSH) |
3,766 |
3,497 |
$41K |
| 80061 |
Lipid panel |
4,652 |
4,293 |
$40K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
391 |
268 |
$39K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
878 |
786 |
$33K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
358 |
324 |
$33K |
| 87660 |
|
2,174 |
1,989 |
$33K |
| 87510 |
|
2,174 |
1,989 |
$33K |
| 87480 |
|
2,174 |
1,989 |
$33K |
| 80076 |
|
8,642 |
7,702 |
$32K |
| 76813 |
|
407 |
364 |
$31K |
| 80047 |
|
8,763 |
7,702 |
$31K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
919 |
873 |
$30K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
4,659 |
4,326 |
$28K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
130 |
124 |
$26K |
| 81001 |
|
16,289 |
14,360 |
$25K |
| 83880 |
|
1,188 |
1,026 |
$23K |
| 43249 |
|
19 |
12 |
$21K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
1,166 |
1,033 |
$20K |
| 81003 |
|
14,059 |
11,655 |
$20K |
| J2469 |
Injection, palonosetron hcl, 25 mcg |
64 |
37 |
$19K |
| 76820 |
|
447 |
228 |
$19K |
| 83735 |
|
4,683 |
3,831 |
$19K |
| 77334 |
|
131 |
62 |
$19K |
| 83605 |
|
2,814 |
2,351 |
$18K |
| 87522 |
Neg quan hep c or qual rna |
757 |
684 |
$17K |
| 85379 |
|
2,425 |
2,116 |
$15K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
3,791 |
3,216 |
$14K |
| J1439 |
Injection, ferric carboxymaltose, 1 mg |
22 |
12 |
$14K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
879 |
807 |
$14K |
| 80305 |
|
1,259 |
754 |
$13K |
| 86317 |
|
1,042 |
891 |
$12K |
| 86803 |
|
1,090 |
960 |
$12K |
| 82607 |
|
1,209 |
1,035 |
$11K |
| 85014 |
|
13,564 |
11,839 |
$10K |
| 82728 |
|
1,291 |
1,064 |
$10K |
| 87340 |
|
1,639 |
1,451 |
$10K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
735 |
654 |
$10K |
| 99201 |
|
192 |
169 |
$9K |
| 86780 |
|
899 |
806 |
$9K |
| 87276 |
|
1,573 |
1,243 |
$9K |
| 87275 |
|
1,573 |
1,243 |
$8K |
| 86140 |
|
2,468 |
2,172 |
$8K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
346 |
131 |
$8K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
890 |
830 |
$8K |
| 92526 |
|
49 |
29 |
$7K |
| 87902 |
|
83 |
69 |
$7K |
| 62370 |
|
71 |
55 |
$6K |
| 82746 |
|
701 |
595 |
$6K |
| 83550 |
|
1,297 |
1,061 |
$6K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
338 |
311 |
$6K |
| 84702 |
|
641 |
396 |
$6K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
40 |
37 |
$6K |
| 86850 |
|
1,086 |
966 |
$5K |
| 83540 |
|
1,302 |
1,065 |
$5K |
| 80349 |
|
109 |
65 |
$5K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
30 |
12 |
$4K |
| 74018 |
|
24 |
24 |
$4K |
| 88142 |
|
331 |
303 |
$4K |
| 84704 |
|
676 |
597 |
$4K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
336 |
296 |
$4K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
78 |
52 |
$4K |
| 84144 |
|
178 |
102 |
$3K |
| 86762 |
|
241 |
215 |
$3K |
| 85610 |
|
1,497 |
1,277 |
$3K |
| 97162 |
|
25 |
24 |
$3K |
| 97113 |
|
37 |
13 |
$3K |
| 20610 |
|
16 |
13 |
$3K |
| 86706 |
|
417 |
371 |
$3K |
| 82951 |
|
245 |
223 |
$3K |
| 86900 |
|
1,178 |
1,041 |
$3K |
| 73110 |
|
44 |
37 |
$3K |
| 86901 |
|
1,178 |
1,041 |
$3K |
| 86704 |
|
368 |
326 |
$3K |
| 73610 |
|
62 |
51 |
$2K |
| 86708 |
|
321 |
287 |
$2K |
| 82947 |
|
2,947 |
2,604 |
$2K |
| 84163 |
|
373 |
336 |
$2K |
| 82330 |
|
2,596 |
2,291 |
$2K |
| 82803 |
|
177 |
142 |
$2K |
| 97161 |
|
13 |
12 |
$2K |
| 87428 |
|
77 |
62 |
$2K |
| 82105 |
|
205 |
178 |
$2K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
122 |
62 |
$2K |
| 82677 |
|
88 |
80 |
$2K |
| 82565 |
|
2,878 |
2,534 |
$2K |
| 77300 |
|
15 |
12 |
$1K |
| 85730 |
|
397 |
326 |
$1K |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
39 |
38 |
$1K |
| 85027 |
|
274 |
243 |
$1K |
| 82150 |
|
285 |
246 |
$1K |
| 83970 |
|
79 |
76 |
$1K |
| 85652 |
|
964 |
848 |
$1K |
| 84132 |
|
2,598 |
2,286 |
$1K |
| 84295 |
|
2,554 |
2,260 |
$1K |
| 82784 |
|
233 |
175 |
$1K |
| 86336 |
|
88 |
80 |
$1K |
| 83516 |
|
182 |
116 |
$991.05 |
| 84520 |
|
2,602 |
2,283 |
$988.30 |
| 82043 |
|
274 |
255 |
$960.27 |
| 82570 |
|
301 |
275 |
$932.00 |
| 82435 |
|
2,546 |
2,254 |
$916.78 |
| 82731 |
|
56 |
40 |
$864.21 |
| 84439 |
|
180 |
137 |
$857.19 |
| 82374 |
|
2,453 |
2,177 |
$843.94 |
| 83883 |
|
167 |
146 |
$842.70 |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
30 |
27 |
$829.36 |
| 87070 |
|
2,762 |
1,841 |
$803.22 |
| 83010 |
|
167 |
146 |
$738.10 |
| 84100 |
|
272 |
247 |
$634.55 |
| 82977 |
|
167 |
146 |
$452.66 |
| 87536 |
|
13 |
12 |
$407.64 |
| 87040 |
|
83 |
42 |
$395.26 |
| 84460 |
|
411 |
369 |
$349.90 |
| 87205 |
|
2,711 |
1,827 |
$341.87 |
| 82172 |
|
167 |
146 |
$341.55 |
| 73630 |
|
18 |
14 |
$306.63 |
| 85018 |
|
323 |
297 |
$261.34 |
| 86225 |
|
142 |
126 |
$246.24 |
| 82465 |
|
161 |
147 |
$237.38 |
| 87077 |
|
644 |
362 |
$224.98 |
| 86039 |
|
139 |
122 |
$161.80 |
| 82010 |
|
30 |
27 |
$158.35 |
| 84480 |
|
14 |
13 |
$143.33 |
| 86200 |
|
143 |
130 |
$141.09 |
| 82247 |
|
148 |
131 |
$137.40 |
| 86308 |
|
19 |
12 |
$95.28 |
| 87186 |
|
422 |
260 |
$91.98 |
| 80069 |
|
35 |
29 |
$81.12 |
| 83615 |
|
18 |
13 |
$79.53 |
| 82550 |
|
101 |
85 |
$55.39 |
| 86431 |
|
126 |
113 |
$55.02 |
| 82950 |
|
12 |
12 |
$52.25 |
| 84550 |
|
12 |
12 |
$42.60 |
| 87210 |
|
29 |
27 |
$39.48 |
| J3490 |
Unclassified drugs |
293 |
215 |
$38.63 |
| 82948 |
|
233 |
36 |
$33.44 |
| 82553 |
|
21 |
13 |
$16.26 |
| 99459 |
|
135 |
118 |
$0.00 |
| J2704 |
Injection, propofol, 10 mg |
81 |
75 |
$0.00 |
| A0428 |
Ambulance service, basic life support, non-emergency transport, (bls) |
331 |
294 |
$0.00 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
534 |
398 |
$0.00 |
| 0064U |
|
145 |
126 |
$0.00 |
| C1755 |
Catheter, intraspinal |
52 |
40 |
$0.00 |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
42 |
40 |
$0.00 |
| J1642 |
Injection, heparin sodium, (heparin lock flush), per 10 units |
304 |
123 |
$0.00 |
| A0427 |
Ambulance service, advanced life support, emergency transport, level 1 (als 1 - emergency) |
39 |
27 |
$0.00 |
| 0065U |
|
16 |
16 |
$0.00 |
| A0425 |
Ground mileage, per statute mile |
699 |
520 |
$0.00 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
279 |
187 |
$0.00 |
| 86235 |
|
26 |
13 |
$0.00 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
160 |
121 |
$0.00 |